Stefano Magon is a Biomarker Experimental Medicine Leader at Roche, bringing extensive experience in the hospital and healthcare sector. With a proven track record in drug development, neuroimaging, and psychology, they have held pivotal roles such as Principal Investigator at University Hospital Basel and Group Head at MIAC AG. Magon holds a PhD focused on neuroplasticity and neurodegeneration from Università degli Studi di Siena and is currently pursuing a Master's degree in Experimental Psychology at Università degli Studi di Padova. Their academic and research contributions span institutions including Università degli Studi di Trento and Indiana University Bloomington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices